BiotechTube
Magnetic Insight

Magnetic Insight

Alameda, United States· Est.
magneticinsight.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15.5M

Overview

Magnetic Insight is a pioneer in commercializing Magnetic Particle Imaging (MPI), a novel modality that directly images magnetic nanoparticles with high sensitivity and quantitation. Founded in 2014 and based in Alameda, California, the company targets the preclinical research market with its MOMENTUM™ imaging system while laying the groundwork for clinical translation in areas like lung perfusion and cancer imaging. As a private company, it is positioned at the intersection of advanced diagnostics and therapeutic monitoring, seeking to establish MPI as a new standard in functional and molecular imaging.

OncologyCardiovascularNeurology

Technology Platform

Magnetic Particle Imaging (MPI) systems and software for quantitative, high-contrast imaging of magnetic nanoparticles.

Funding History

2
Total raised:$15.5M
Series B$10M
Series A$5.5M

Opportunities

MPI addresses limitations of current imaging modalities by offering radiation-free, quantitative, and high-contrast imaging, creating opportunities in dynamic perfusion imaging and sensitive cell tracking.
The growing focus on targeted therapies and personalized medicine drives demand for advanced imaging tools in both preclinical research and clinical monitoring.
Successful clinical translation in a key area like lung perfusion could open a large new diagnostic market.

Risk Factors

MPI is a novel modality competing against deeply entrenched and versatile technologies like MRI and CT, posing a significant market adoption challenge.
The regulatory pathway for new clinical imaging indications is long, costly, and uncertain.
The company's success is also dependent on the concurrent development and regulatory approval of optimized magnetic nanoparticle tracers.

Competitive Landscape

In preclinical imaging, Magnetic Insight competes with established players selling MRI, PET/CT, and optical imaging systems (e.g., Bruker, PerkinElmer). For future clinical applications, it would compete with the entire medical imaging industry, including giants like GE HealthCare, Siemens Healthineers, and Philips, who dominate with MRI, CT, and nuclear medicine systems. Its competitive edge lies in MPI's unique technical capabilities, but it faces a steep challenge in displacing existing standard-of-care modalities.

More companies in Diagnostics & Precision Medicine →More companies in United States →